Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance;Polimorfismo de la proteína ligante de ácidos grasos intestinal (FABP2), obesidad e insulina resistencia

Revista Medica de Chile

Volumn 134, Issue 3, 2006, Pages 372-379

  Albala B, Cecilia ^a   Jiménez R, Beatriz ^b   Pérez B, Francisco ^a   Liberman G, Claudio ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Diabetes mellitus; FABP2 protein, human; Fatty acid binding proteins; Obesity

Indexed keywords

FABP2 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN;

FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; PHYSIOLOGY; REVIEW;

FATTY ACID-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; POLYMORPHISM, GENETIC;

EID: 33646485084     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. MERCADO MM, MCLENITHAN JC, SILVER KD, SHULDINER AR. Genetic of Insulin Resistance. Curr Diab Rep 2002; 2: 83-95.
2. DAMCOTT CM, SACK P, SHULDINGER AR. The genetics of obesity. Endocrinol Metab Clin N Am 2003; 32: 761-86.
3. ELBEIN SC, MAXWELL TM, SCHUMACHER MC. Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings. Diabetes 1991; 40: 1024-32.
4. MAYER EJ, NEWMAN B, AUSTIN MA, QUESENBERRY CP, EDWARDS K, SELBY JB. Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins. Am J Epidemiol 1996; 146: 323-32.
5. WAISS EP, BROWN MD, SHULDINER AR, HAGBERG JM. Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene- environment interactions effects. Physiol Genomics 2002; 10: 145-57.
6. BERNLOHR DA, SIMPSON MA, VOGELHERTZEL A, BANASZAK LJ. Intracellular lipid-binding proteins and their genes. Ann Rev Nutr 1997; 17: 277-303.
7. HSU KT, STORCH J. Fatty acid transfer from liver and intestinal fatty acid binding proteins to membranes occurs by different mechanisms. J Biol Chem 1996; 271: 13317-23.
8. SPARKES RS, MOHANDAS T, HEINZMANN C, GORDON JI, KLISAK I, ZOLLMAN S ET AL. Human fatty acid binding protein assignments: intestinal to 4q28-4q31 and liver to 2p11. (Abstract) Cytogenet Cell Genet 1987; 46: 697.
9. ORDOVAS JM. Genetics, postprandial lipemia and obesity. Nutr Metab Cardiovasc Dis 2001; 11: 118-33.
10. BERTHIER MT, COUILLARD C, PRUDHOMME D, NADEAU A, BERGERON J, TREMBLAY A ET AL. Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men. Obes Res 2001; 9: 668-75.
11. LEWIS MR, TRACY RP. The role of the immune system in the insulin resistance syndrome. Curr Diab Rep 2002; 2: 96-9.
12. BAIER LJ, BOGARDUS C, SACCHETTINI JC. A Polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco 2 cells. J Biol Chem 1996; 271: 10892-6.
13. LEVY E, MENARD D, DELVIN E, STANT S, MITCHELL G, LAMBERT M ET AL. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem 2001; 276: 39679-84.
14. BAIER LJ, SACCHETTINI JC, KNOWLER WC, EADS J, PAOLISSO G, TATARANNI PA ET AL. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation and insulin resistance. J Clin Invest 1995; 95: 1281-7.
15. KIM CH H, YUN SK, BYUN DW, YOO MH, LEE KU, SUH KL. Codon 54 polymorphism of the FABP2 gene is associated with increased fat oxidation and hyperinsulinemia but not with intestinal fatty acid absorption in Korean men. Metabolism 2001; 50: 473-6.
16. YAMADA K, YUAN X, ISHIYAMA S, KOYAMA K, ICHIKAWA F, KOYANAGI A ET AL. Association between Ala54Thr substitution on the fatty binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 1997; 40: 706-10.
17. CARLSSON M, ORHO-MELANDER M, HEDENBRO J, ALMGREN P, GROOP LC. The T 54 allele of the intestinal fatty acid binding protein 2 is associated with parental story of stroke. J Clin Endocrinol Metab 2000; 85: 2801-4.
18. HEGELE RA, CONNELLY PW, HANLEY AJ, SUN F, HARRIS SB, ZINMAN B. Common genomic variants associated with variations in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol 1997; 17: 1060-6.
19. ALBALA C, SANTOS JL, CIFUENTES M, VILLARROEL AC, LERA L, LIBERMAN C ET AL. Intestinal FABP2 A54T polymorphism: Association with insulin resistance and obesity in women. Obes Res 2004; 12: 340-5.
20. ALBALA C, ANGEL B, LERA L, CIFUENTES M, VILLARROEL AC, SANTOS JL ET AL. Variants in the human Intestinal Fatty Acid Binding protein 2 gene in Chilean elders. Obes Res 2003, 11(supp) 47.
21. PÉREZ-BRAVO F, FUENTES M, ANGEL B, CIFUENTES M, CARRASCO E, SANTOS J ET AL. Lack of Association Between the Fatty Acid Binding Protein 2 (Fabp-2) Polymorphism With Obesity and Insulin-Resistance in two Aboriginal Populations from Chile. Eur J Med Genet 2006, en prensa.
22. MATTHEWS DR, HOSKER JP, RUDENSKI AS, NAYLOR BA, TREACHER DF, TURNER RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations. Diabetologia 1985; 28: 412-18.
23. BROWN M, SHULDINER A, FERRELL R, WEISS E, KORYTKOWSKI ZMUDA J, MCCOLE S ET AL. FABP2 genotype is associated with insulin sensitivity in older women. Metabolism 2001; 50: 1102-5.
24. CHUI KC, CHUAN L-M, YOON C. The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians. BMC Genetics 2001; 2: 7-15.
25. MITCHELL B, KAMMERER C, O'CONNELL C, HARRISON CH, MANIRE M, SHIPMEN P ET AL. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid binding protein (FABP2) in Mexican-Americans. Diabetes 1995; 44: 1046-53.
26. ITO K, NAKATANI K, FUJI M, KATSUKI A, TSUCHIHASHI K, MURATA K ET AL. Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population. Diabetic Medicine 1999; 16: 119-24.
27. TAKAKURA Y, YOSHIOKA K, UMEKAWA T, KOGURE A, TODA H, YOSHIKAWA T ET AL. Thr54 allele of the FABP2 gene affects resting metabolic rate and visceral obesity. Diab Res Clin Pract 2005; 67: 36-42.
28. XIANG K, ZHENGT, JIA W, SUN D, DING W, LI J ET AL. The association of Ala54Thr variant of intestinal fatty acid binding protein gene with general and regional adipose tissue depots. Chin Med Sci J 1999; 14: 46-51.
29. LEI H, CORESH J, SCHULDINER A, BOERWINKLE E, BREANCATI F. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity and hyperinsulinemia in African-Americans. Diabetes 1999; 48: 1868-72.
30. SIPILAÏNEN R, UUSITUPA M, HEIKKINEN S, RISSANEN A, LAAKSO M. Variants in the Human fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab 1997; 82: 2629-32.
31. ENDO K, YANAGI H, HIRANO C, HAYAKAWA Y, HAMAGUSHI H, TOMURA S. No association found between the Ala54Thr polymorphism of FABP2 gene and obesity and obesity with dyslipidemia in Japanese school children. J Atheroscler Thromb 2001; 8: 80-3.
32. DUARTE NL, COLAGIURI S, PALU T, WANG XL, WILCKEN DE. Obesity, type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population. Mol Genet Metab 2003; 79: 183-8.
33. CAMPAGNA F, MONTALI A, BARONI G, MARIA AT, RICCI G, ANTONINI R ET AL. Common variants in the lipoprotein lipase gene, but not those in the insulin substrate-1, the beta3-adrenergic receptor and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia. Metabolism 2002; 51: 1298-305.
34. BERTOLINI S, PISCIOTTA L, DI SCALA L, LANGHEIM S, BELLOCCHIO A, MASTURZO P ET AL. Genetic polymorphism affecting the phenotypic expression of familial hypercholesterolemia. Atherosclerosis 2004; 174: 57-65.
35. RENNER W, PRESSL H, WASCHER TC, PAULWEBER B, IGLSEDER B. The role of the A54T polymorphism of the intestinal fatty acid binding protein for lipid levels, insulin sensitivity and carotid atherosclerosis. Atherosclerosis 2004; 173: 137-9.
36. GUETTIER JM, GEORGOPOULOS A, TSAI MY, RADHA V, SHANTHIRANI S, DEPPA R ET AL. Polymorphism in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in South Indian population. J Clin Endocrinol Metab 2005; 90: 1705-11.
37. ENDRES S, GHORBANI R, KELLEY VE, GEORGILIS K, LONNEMANN G, VAN DER MEER JW ET AL. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 256-71.
38. RICHIERI GV, OGATA RT, KLEINFELD AM. Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J Biol Chem 1994; 269: 23918-30.
39. AGREN J, VIDGREN H, VALVE R, LAAKSO M, UUSITUPA M. Postprandial responses of individual fatty acids in subjects homozygous for the threonine or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am J Clin Nutr 2001; 73: 31-5.
40. DWORATZEK P, HEGELE R, WOLEVER T. Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid binding protein 2 gene is dependent on the type of fat ingested. Am J Nutr 2004; 79: 1110-17.
41. VASSILEVA G, HUWYLER L, POIRIER K, AGELLON LB, TOTH MJ. The intestinal fatty acid binding protein is not essential for dietary fat absortion in mice. FASEB J 2000; 14: 2040-6.
42. FORMANACK ML, BAIER LJ. Variation in the FABP2 promoter affects gene expression: implications for prior association studies. Diabetologia 2004; 47: 349-51.
43. YANAGISAWA Y, KAWABATA T, TANAKA O, KAWAKAMI M, HASEGAWA K, KAGAWA Y. Improvement in blood lipid levels by dietary sn-1,3-diacylglycerol in young women with variants of lipid transporters 54T-FABP2 and -493-MTP. Biochem Biophys Res Commun 2003; 302: 743-50.
44. RIBALTA J, HALKES CJ, SALAZAR J, MASANA L, CABEZAS MC. Additive effects of the PPAR gamma, APOE and FABP-2 genes in increasing daylong triglycerides of normolipidemic women to concentrations comparable to those in men. Clin Chem 2005; 51: 864-71.